Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 6826 to 6840 of 7680 results

  1. Accident and emergency departments

    Discontinued [GID-SGWAVE0762]

    Safe staffing guideline
    Discontinued

  2. Hypercholesterolemia - mipomersen [ID524]

    Discontinued [GID-TAG437]

    Technology appraisal guidance
    Discontinued

  3. Autologous chondrocyte implantation using 3D collagen matrix (novocart 3D) for treating articular cartilage defects of the knee [ID2707]

    In development [GID-TA10667] Expected publication date: TBC

    Technology appraisal guidance
    In development

  4. Nivolumab for untreated advanced hepatocellular carcinoma [ID1248]

    Discontinued [GID-TA10221]

    Technology appraisal guidance
    Discontinued

  5. Belantamab mafodotin for treating relapsed or refractory multiple myeloma after 2 therapies [ID5108]

    In development [GID-TA11018] Expected publication date: TBC

    Technology appraisal guidance
    In development

  6. Filgotinib for treating moderately to severely active Crohn's disease [ID6236]

    In development [GID-TA11244] Expected publication date: TBC

    Technology appraisal guidance
    In development

  7. GID-MT567 Evoke Spinal Cord Stimulator for managing chronic neuropathic or ischaemic pain

    In development [GID-MT567] Expected publication date: TBC

    Medical technologies guidance
    In development

  8. Venetoclax with ibrutinib and obinutuzumab for untreated chronic lymphocytic leukaemia ID1270

    Discontinued [GID-TA10211]

    Technology appraisal guidance
    Discontinued

  9. Relatlimab with nivolumab for treating advanced malignant melanoma after immunotherapy in people over 12 [ID1612]

    Discontinued [GID-TA10484]

    Technology appraisal guidance
    Discontinued

  10. Ivosidenib for treating relapsed or refractory IDH1-positive acute myeloid leukaemia [ID1548]

    Discontinued [GID-TA10416]

    Technology appraisal guidance
    Discontinued

  11. Levitronix CentriMag for treatment of refractory cardiogenic shock or severe cardiopulmonary insufficiency (discontinued)

    Discontinued [GID-MT130]

    Medical technologies guidance
    Discontinued

  12. SILK artery reconstruction device (discontinued)

    Discontinued [GID-MT81]

    Medical technologies guidance
    Discontinued

  13. Clinitek Microalbumin 9 reagent strips for the early detection and monitoring of kidney disease (discontinued)

    Discontinued [GID-MT163]

    Medical technologies guidance
    Discontinued

  14. Paclitaxel as albumin-bound nanoparticles with gemcitabine for adjuvant treatment of pancreatic cancer [ID1413]

    Discontinued [GID-TA10329]

    Technology appraisal guidance
    Discontinued

  15. Mogamulizumab for previously treated T-cell leukaemia-lymphoma [ID1390]

    Discontinued [GID-TA10464]

    Technology appraisal guidance
    Discontinued